V-CHECK is dedicated to provide reliable and cost-effective in vitro diagnostic products for women’s diseases, particularly for those without sensitive biomarkers for early diagnosis.
UNLV Office of Technology Transfer and Economic Development
UNLV is Nevada’s premier public research university and a powerhouse for groundbreaking discovery and innovation, particularly in life sciences and biotechnology. At the forefront of UNLV’s industry and business engagement are our dynamic offices of Economic Development and Technology Transfer, serving as vital connectors between pioneering research and impactful commercialization opportunities. UNLV’s cutting-edge Brain Health Department as well as the innovative Wastewater Surveillance Laboratory exemplify our bold approach to solving complex health and environmental challenges. Researchers at these centers drive groundbreaking advancements with profound implications for neuroscience, public health, environmental monitoring, and disease prevention. Uniquely situated within a collaborative and vibrant regional ecosystem, UNLV thrives alongside major stakeholders committed to ambitious, strategic coordination and innovative thinking. This environment enables business and industry partnerships to flourish, supported by open communication and outside-the-box planning that accelerate shared success. At BIO International 2025, our goal is clear: to connect industry leaders, visionaries, and partners directly with UNLV’s exceptional talent, transformative research capabilities, and rich pipeline of licensable technologies. Opportunities abound at UNLV for collaborative sponsored research, tailored workforce development programs, robust startup incubation support, and access to patented university technologies poised for commercialization. Discover how partnering with UNLV can propel your organization’s priorities forward through innovative solutions and collaborations. Connect with us at BIO to harness the full potential of our research excellence and vibrant innovation ecosystem. | UNLV, a Carnegie R1 research institution, is a key player in the delegation’s efforts. UNLV emphasizes industry engagement through opportunities for students, strong bio research, innovation, a collaborative research and technology park, and commercialization of life-changing products in fields like life science, physical science, and engineering. UNLV is seeking to connect with BIOtech companies and explore collaboration opportunities.
UNESP
Sao Paulo State University and V-BioPharma, a brazilian CDMO
The Hong Kong Polytechnic University
With 85 years of proud tradition and ranking among the world’s top 100 institutions, The Hong Kong Polytechnic University (PolyU) aspires to be a leading university with world-class research and education. Our holistic professional education, which embraces new technologies, entrepreneurship, and service-learning, aims to nurture graduates who not only possess a competitive edge in their disciplinary knowledge, but also develop into socially responsible leaders. As a university with a strong emphasis on societal impact, PolyU is devoted to providing interdisciplinary solutions for major social challenges through advanced research and knowledge transfer activities. Our innovations have opened up new horizons in space, improved health and well-being, boosted economic efficiency, and fostered sustainability for a better world. Our strong culture of knowledge transfer and entrepreneurship helps transform our research breakthroughs into real-world applications. Looking to the future, PolyU will continue its pursuit of excellence, cultivating talent who serve society with passion, and contributing to the development of Hong Kong as an international innovation and technology hub in the Greater Bay Area. We will carry on manifesting the spirit of the University’s Motto: To learn and to apply, for the benefit of mankind. | With 86 years of proud tradition and ranking among the world’s top 100 institutions, The Hong Kong Polytechnic University (PolyU) aspires to be a leading university with world-class research and education. Our holistic professional education, which embraces new technologies, entrepreneurship, and service-learning, aims to nurture graduates who not only possess a competitive edge in their disciplinary knowledge, but also develop into socially responsible leaders. As a university with a strong emphasis on societal impact, PolyU is devoted to providing interdisciplinary solutions for major social challenges through advanced research and knowledge transfer activities. Our innovations have opened up new horizons in space, improved health and well-being, boosted economic efficiency, and fostered sustainability for a better world. Our strong culture of knowledge transfer and entrepreneurship helps transform our research breakthroughs into real-world applications. Looking to the future, PolyU will continue its pursuit of excellence, cultivating talent who serve society with passion, and contributing to the development of Hong Kong as an international innovation and technology hub in the Greater Bay Area. We will carry on manifesting the spirit of the University’s Motto: To learn and to apply, for the benefit of mankind. | The Hong Kong Polytechnic University (PolyU) aspires to be an innovative world-class university that pursues excellence in education, research and knowledge transfer. Driven by its motto, “To learn and to apply, for the benefit of mankind”, the University nurtures socially responsible professionals and leaders and pursues world-leading research and innovation for societal benefits. | With 85 years of proud tradition and ranking among the world’s top 100 institutions, The Hong Kong Polytechnic University (PolyU) aspires to be a leading university with world-class research and education. We strive in inter-disciplinary research and impactful innovations to address real-world challenges.
SUPERA PARQUE
SUPERA Park is an innovative environment that promotes knowledge transfer in several types of activities. It is responsible for attracting and retaining technology-based companies, with noteworthy mention to the Health, Biotechnology, Information Technology and Bioenergy industries. SUPERA Park was built within the University of São Paulo (USP) – one of the best universities in Brazil, Fact that makes it easier to find qualified people and hard science knowledge. SUPERA Park has many activities to support startups to validate and build a solid business model. Based on this, we have one of the best business incubator in Brazil (top 20 world universities in the 2019 UBI benchmark), 9 different laboratories for technical tests and validation, an international department and 3 clusters (health, software and beer) supported by our team. We also represent a number of startups that are looking for new partnerships and customers for their solutions. | SUPERA is the technology park of Ribeirão Preto, one of the most important scientific centers in the country. Our main programs are the Business Incubator, Open Innovation Program and Softlanding Program for international companies wishing to settle in Brazil. | SUPERA Innovation and Technology Park is a dynamic innovation ecosystem located in Ribeirão Preto, São Paulo, Brazil, and is linked to the University of São Paulo (USP) – Ribeirão Preto campus. SUPERA Park is a reference center for science, technology, and innovation, fostering entrepreneurship, knowledge-based businesses, and technological development. Core Mission: SUPERA Park supports the development and growth of startups, scale-ups, and innovative companies, particularly in the fields of biotechnology, life sciences, health, information technology, and advanced manufacturing. It provides infrastructure, business development support, and access to networks that drive innovation and competitiveness. Key Activities and Services: – Business Incubation and Acceleration: Programs for startups and scale-ups, offering mentoring, business modeling, market validation, and growth strategies. – Softlanding Programs: Support for international companies entering the Brazilian market and Brazilian companies aiming to internationalize. – Collaborative R&D Support: Facilitation of partnerships between companies, universities, and research centers for research, development, and innovation (R&D&I) projects. – Innovation Programs: Open innovation initiatives connecting corporations with startups and researchers to solve business challenges. – Infrastructure: High-standard office spaces, laboratories, coworking areas, and access to specialized facilities in biotechnology, pharmaceuticals, agritech, healthtech, and ICT. – Matchmaking and Networking: Connection to investors, corporate partners, academic experts, and government agencies to foster business and technology development. – International Cooperation: Support for international collaborative projects, technology transfer, and partnerships with global innovation ecosystems. Key Sectors of Focus: – Biotechnology – Pharmaceuticals and HealthTech – Medical Devices – Agritech and Bioinputs – Digital Health and ICT – Clean Technologies
SRM Institute of Science and Technology (SRMIST)
SRM Institute of Science and Technology (formerly known as SRM University) is one of the top ranking universities in India, offering a wide range of undergraduate, postgraduate and doctoral programs in Engineering, Management, Medicine and Health sciences, and Science and Humanities.
Seoul National University R&DB Foundation
Discover the Power of Innovation at the Seoul National University Pavilion | BIO International 2025, Boston Join us in Boston at BIO 2025 and experience the forefront of biomedical innovation through the Seoul National University (SNU) Pavilion, where academic excellence meets translational impact. At the SNU R&DB Foundation, we champion world-class research by managing intellectual property, accelerating technology transfer, and advancing commercialization. We foster interdisciplinary collaboration, empower academia-industry partnerships, and nurture entrepreneurial growth among SNU’s researchers and students. At Booth #2879, we are proud of presenting a curated selection of next-generation technologies available for global licensing and collaboration, including: • First-in-class small molecules and antibodies targeting liver cancer and MASH • Novel peptides with superior hair growth efficacy • Broad-spectrum antibiotics with powerful efficacy against multidrug-resistant superbugs, developed through drug repositioning • Short peptides with a new mode of action offering both anti-inflammatory and anti-cancer effects, including IBD • Next-generation mesothelin-targeting antibody engineered to overcome proteolytic degradation; and • More game-changing innovations shaping the next era of biotechnology. Explore the future of Korean biotech through seven innovative SNU spin-off companies, each pushing the boundaries of science and commercialization: AIGENDRUG | AI-driven drug discovery platform(DrugVLAB) | www.aigendrug.com CellBion | Radiopharmaceuticals & radioligand therapy | www.cellbion.co.kr CELLinCELLS | Organoid tissue module manufacturing technology | www.cellincells.com ClichemBIO, Inc. | Albumin-based nano theranostics platform for precision nano-medicine | www.clichembio.com Molecular Innovations Inc. | Multifunctional small molecules (Resveratron) for improving skin health and metabolic diseases NIBEC | Proprietary peptides, regenerative biomaterials, and drug delivery systems | https://nibec.co.kr/en/ Portrai | Spatial Transcriptomics-based Drug Discovery Solutions and AI Pathology Analysis System | www.portrai.io We cordially invite you to visit the SNU Pavilion and explore powerful opportunities for partnership, co-development, and strategic investment. Let’s build the future of biotech—together. Meet us in Boston, and let innovation begin. | Seoul National University (SNU) Pavilion | BIO International Convention 2026 Discover Partner-Ready Innovation from One of Asia’s Leading Research Universities Join the Seoul National University (SNU) Pavilion at BIO 2026 and connect with a premier hub of translational research and global partnering. Backed by a strong track record in intellectual property management, technology transfer, and successful commercialization, the SNU R&DB Foundation serves as the gateway to high-impact biomedical innovations from Korea’s top-ranked university. We actively collaborate with global pharmaceutical and biotech partners to advance early-stage assets toward clinical and commercial success. Our portfolio is built on rigorous science, validated targets, and strong IP positions—designed for efficient licensing and co-development. We will be showcasing selected innovations at Booth #5535 ○ Hepatitis B virus-derived polypeptides and their therapeutic applications ○ An antibacterial or antifungal composition for preventing or treating bacterial or fungal infections (featuring VLX600) ○ Anti-AXL (and Anti-MERTK) antibody and composition containing the same ○ Novel isoxazole compounds as TM4SF5-specific inhibitors and their therapeutic applications ○ Fc Variants for Modulating FcRn Function ○ Novel CD89(Fc α receptor) binding antibodies and their therapeutic applications Explore a curated lineup of innovative SNU spin-off companies, each advancing breakthrough science toward real-world impact and global commercialization. ○ AIGENDRUG | AI Drug Discovery Platform(DrugVLAB) ○ CellBion | Radioligand therapeutics and diagnostics for prostate cancer ○ CELLinCELLS | 3D Tissue Reforming Technology Platform technology, TRTP-101, TRTP-20X ○ ClichemBIO, Inc. | Albumin nanoplatform, New Drug Development ○ NIBEC | Medical Device, Pepetide CDMO, Peptide-based therapeutics ○ SJChem Meditech, Inc | Oral Drug for Atopic Dermatitis ○ Qureator, Inc. | Curiochips®, Human Disease Models, QuriCore AI™ Platform Meet our team to explore partnership opportunities aligned with your pipeline strategy. Pre-arranged meetings are highly encouraged for in-depth discussions and confidential data sharing.
Rhode Island Life Science Hub & RI Bio Pavilion
Join us at the Bio 2025 Rhode Island Pavilion, a collaborative initiative by the Rhode Island Life Science Hub and RI Bio. This pavilion showcases Rhode Island’s dynamic life sciences sector, highlighting groundbreaking innovations and fostering partnerships among industry leaders, academic institutions, and healthcare organizations. Discover how Rhode Island is advancing biotechnology to improve lives and drive economic growth.
Quanttrace
Quanttrace: Pioneering Non-Invasive Therapeutic Drug Monitoring Quanttrace is a spin-off from the Laboratory of Neuroengineering at the National University of San Martín (UNSAM, Buenos Aires, Argentina). We are pioneers in non-invasive therapeutic drug monitoring, developing devices that personalize healthcare without interfering with patients’ daily lives. Successful pharmacological treatment relies on patient adherence. However, even perfect adherence can’t prevent plasma level variability due to individual differences in absorption, metabolism, and sensitivity. Personalized medicine aims for optimal drug levels tailored to each individual, especially for medications with narrow therapeutic ranges (such as oncologic drugs, antipsychotics, anticonvulsants, and antibiotics). Our challenge at Quanttrace is to provide the pharmaceutical and biotech industries with in-situ methods for measuring plasma concentrations without disrupting daily routines. Our technology is wearable, non-invasive, and works in everyday environments without laboratory equipment. Data is processed on a mobile device, and results are immediate. Quanttrace merges complex signal analysis and AI tools with advanced medicinal chemistry, allowing patients and caregivers to monitor plasma drug concentration at home and communicate directly with their doctors. This represents a significant advancement towards precision medicine and in-situ dose control, ensuring optimal treatment adherence. At Quanttrace we are currently conducting preclinical trials in small and large animals to validate our technology. At this stage, we have filed a provisional patent to protect our innovation. Right now we are actively seeking investment to refine our development and successfully conclude our preclinical trials and go into a clinical phase of research. We are open to hearing from investors who wish to partner with us in this innovative and exciting research pipeline. keywords: personalized medicine, precision medicine, precision healthcare, patient monitoring device, in-situ dose control, therapeutic drug monitoring, artificial intelligence, AI, medicinal chemistry, at home monitoring.